While an adverse event reported in Intellia’s gene therapy trial was a “non-concern” for analysts, it follows a handful of ...

Teos expects to absorb nearly $25 million in one-time costs for severance and termination payments. The biotech had 173 ...

The canceled contract comes as Moderna nears a critical FDA decision for its next-generation COVID-19 vaccine.

Patritumab deruxtecan was unable to significantly improve overall survival in patients with locally advanced or metastatic ...

Looking for a biopharma job in New York? Check out the BioSpace list of seven companies hiring life sciences professionals ...

In a letter to the Department of Commerce, Novo Nordisk argued that unsanctioned compounded semaglutide, mostly from China, ...

It’s called the peak-end rule. People remember two things most about an experience: the most emotionally intense moment and ...

Nearly a third of employed and almost half of unemployed BioSpace survey respondents are seriously considering leaving the ...

Leerink Partners previews the drugs likely to be subject to the Inflation Reduction Act’s next price negotiations as the ...

Acute systemic infection caused the patient to develop fatal capillary leak syndrome, highlighting the unpredictability of ...

R&D spending across the global pharmaceutical sector climbed 1.5% in 2024, according to unreleased data from Evaluate Pharma.

In a video posted to social media on Tuesday, HHS Secretary Robert F. Kennedy, Jr. claimed that there is a lack of clinical ...